The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Polo-like Kinase 1 (Plk1) Inhibits p53 Function by Physical Interaction and Phosphorylation
Open accessAbstract
Polo-like kinase 1 (Plk1) has an important role in the regulation of M phase of the cell cycle. In addition to its cell cycle-regulatory function, Plk1 has a potential role in tumorigenesis. Here we found for the first time that Plk1 physically binds to the tumor suppressor p53 in mammalian cultured cells, and inhibits its transactivation activity as well as its pro-apoptotic function. During the cisplatin-induced apoptosis in human neuroblastoma SH-SY5Y cells, the expression level of Plk1 was significantly decreased both at mRNA and protein levels, whereas cisplatin treatment caused a remarkable stabilization of p53. Systematic immunoprecipitation analyses using a series of deletion mutants of p53 revealed that a sequence-specific DNA-binding region of p53 is required and sufficient for the physical interaction with Plk1. The ectopically overexpressed Plk1 was co-localized with the endogenous p53 in mammalian cell nucleus, as shown by confocal laser microscopy. Expression of exogenous Plk1 and p53 in p53-deficient lung carcinoma H1299 cells greatly decreased the p53-mediated transcription from the p53-responsive p21(WAF1), MDM2, and BAX promoters, whereas the kinase-deficient mutant form of Plk1 failed to reduce the transcriptional activity of p53. Consistent with the luciferase reporter analysis, Plk1 had an ability to block the p53-dependent induction of the endogenous p21(WAF1). In addition, Plk1 inhibited the pro-apoptotic function of p53 in H1299 cells. Intriguingly, Plk1-mediated repression of p53 was attenuated with ATM. Thus, our present findings strongly suggest that p53 is a critical target of Plk1, and its function is abrogated through the physical interaction with Plk1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
The molecular biology of the CCAAT-binding factor NF-Y
Mantovani, R. (1999) · Gene · doi:10.1016/s0378-1119(99)00368-6 · Cited by 861
Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation
Leng, R. P., Lin, Y., Ma, W., Wu, H., Lemmers, B., Chung, S., Parant, J. M., Lozano, G., Hakem, R., & Benchimol, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00193-4 · Cited by 722
Wild-type p53 activates transcription in vitro
Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R., & Prives, C. (1992) · Nature · doi:10.1038/358083a0 · Cited by 579
ATM associates with and phosphorylates p53: mapping the region of interaction
Khanna., K. K., Keating, K. E., Kozlov, S., Scott, S., Gatei, M., Hobson, K., Taya, Y., Gabrielli, B., Chan, D., Lees-Miller, S. P., et al. (1998) · Nature Genetics · doi:10.1038/3882 · Cited by 486
Golsteyn, R. M., Mundt, K. E., Fry, A. M., & Nigg, E. A. (1995) · The Journal of cell biology · doi:10.1083/jcb.129.6.1617 · Cited by 473
Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells
Liu, X., & Erikson, R. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031523100 · Cited by 472
Polo-like kinase-1 is a target of the DNA damage checkpoint
Smits, V. A. J., Klompmaker, R., Arnaud, L., Rijksen, G., Nigg, E. A., & Medema, R. H. (2000) · Nature Cell Biology · doi:10.1038/35023629 · Cited by 440
Polo-like kinases: a team that plays throughout mitosis
Glover, D. M., Hagan, I. M., & Tavares, Á. A. M. (1998) · Genes & Development · doi:10.1101/gad.12.24.3777 · Cited by 424
Phosphorylation of p53 Serine 15 Increases Interaction with CBP
Lambert, P. F., Kashanchi, F., Radonovich, M. F., Shiekhattar, R., & Brady, J. N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.33048 · Cited by 423
Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase
Toyoshima-Morimoto, F., Taniguchi, E., Shinya, N., Iwamatsu, A., & Nishida, E. (2001) · Nature · doi:10.1038/35065617 · Cited by 364
Shaulsky, G., Goldfinger, N., Ben-Ze'ev, A., & Rotter, V (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.12.6565 · Cited by 356
Nuclear and nucleolar targeting sequences of c-erb-A, c-myb, N-myc, p53, HSP70, and HIV tat proteins
Dang, C. V., & Lee, W. M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84673-2 · Cited by 347
Polo-like kinases: positive regulators of cell division from start to finish
Nigg, E. A. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80121-x · Cited by 344
Activation of the p53 tumor suppressor protein
Vousden, K. H. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00035-5 · Cited by 337
Nakajima, H., Toyoshima-Morimoto, F., Taniguchi, E., & Nishida, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300126200 · Cited by 337
Plk1 promotes nuclear translocation of human Cdc25C during prophase
Toyoshima‐Morimoto, F., Taniguchi, E., & Nishida, E. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf069 · Cited by 337
MDM2 suppresses p73 function without promoting p73 degradation
Zeng, X., Chen, L., Jost, C. A., Maya, R., Keller, D., Wang, X., Kaelin, W. G., Oren, M., Chen, J., & Lu, H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3257 · Cited by 334
Spankuch-Schmitt, B., Bereiter-Hahn, J., Kaufmann, M., & Strebhardt, K. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.24.1863 · Cited by 327
Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer
Wolf, G., Elez, R., Doermer, A., Holtrich, U., Ackermann, H., Stutte, H. J., Altmannsberger, H.-M., Rübsamen-Waigmann, H., & Strebhardt, K. (1997) · Oncogene · doi:10.1038/sj.onc.1200862 · Cited by 323
ΔNp73, A Dominant-Negative Inhibitor of Wild-type p53 and TAp73, Is Up-regulated in Human Tumors
Zaika, A. I., Slade, N., Erster, S. H., Sansome, C., Joseph, T. W., Pearl, M., Chalas, E., & Moll, U. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020179 · Cited by 318
Golsteyn, R. M., Schultz, S. J., Bartek, J., Ziemiecki, A., Ried, T., & Nigg, E. A. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.6.1509 · Cited by 278
Holtrich, U., Wolf, G., Bräuninger, A., Karn, T., Böhme, B., Rübsamen-Waigmann, H., & Strebhardt, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1736 · Cited by 275
Smith, M. R., Wilson, M. L., Hamanaka, R., Chase, D., Kung, H.-F., Longo, D. L., & Ferris, D. K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6633 · Cited by 248
Lee, K. S., Grenfell, T. Z., Yarm, F. R., & Erikson, R. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9301 · Cited by 245
Knecht, R., Elez, R., Oechler, M., Solbach, C., von Ilberg, C., & Strebhardt, K. (1999) · PubMed · Cited by 232
Xie, S., Wu, H., Wang, Q., Cogswell, J. P., Husain, I., Conn, C., Stambrook, P., Jhanwar-Uniyal, M., & Dai, W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106050200 · Cited by 227
Functional studies on the role of the C-terminal domain of mammalian polo-like kinase
Jang, Y.-J., Lin, C.-Y., Ma, S., & Erikson, R. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042689299 · Cited by 195
Identification of an early-growth-response gene encoding a novel putative protein kinase.
Simmons, D. L., Neel, B. G., Stevens, R., Evett, G., & Erikson, R. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.9.4164 · Cited by 194
Donohue, P. J., Alberts, G. F., Guo, Y., & Winkles, J. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.10351 · Cited by 191
Nakagawa, T., Takahashi, M., Ozaki, T., Watanabe, K.-I., Todo, S., Mizuguchi, H., Hayakawa, T., & Nakagawara, A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2575-2585.2002 · Cited by 178
Self-citationPolo-like Kinase Is a Cell Cycle-regulated Kinase Activated during Mitosis
Hamanaka, R., Smith, M. R., O'Connor, P. M., Maloid, S., Mihalic, K., Spivak, J. L., Longo, D. L., & Ferris, D. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.36.21086 · Cited by 164
Inhibition of Polo-like Kinase-1 by DNA Damage Occurs in an ATM- or ATR-dependent Fashion
van Vugt, M. A. T. M., Smits, V. A. J., Klompmaker, R., & Medema, R. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101831200 · Cited by 164
Tan, T. H., Wallis, J., & Levine, A. J. (1986) · Journal of Virology · doi:10.1128/jvi.59.3.574-583.1986 · Cited by 162
Clay, F. J., McEwen, S. J., Bertoncello, I., Wilks, A. F., & Dunn, A. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.4882 · Cited by 159
Bahassi, E. M., Conn, C. W., Myer, D. L., Hennigan, R. F., McGowan, C. H., Sánchez, Y., & Stambrook, P. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205850 · Cited by 157
Spänkuch, B., Wolf, G., Solbach, C., Loibl, S., Knecht, R., Stegmüller, M., von Minckwitz, G., Kaufmann, M., & Strebhardt, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205412 · Cited by 149
Li, B., Ouyang, B., Pan, H., Reissmann, P. T., Slamon, D. J., Arceci, R. J., Lu, L., & Dai, W. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19402 · Cited by 145
Inhibition of p53 Transcriptional Activity by the S100B Calcium-binding Protein
Lin, J., Blake, M., Tang, C., Zimmer, D. B., Rustandi, R. R., Weber, D. J., & Carrier, F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104379200 · Cited by 141
Yuan, J., Eckerdt, F., Bereiter‐Hahn, J., Kurunci‐Csacsko, E., Kaufmann, M., & Strebhardt, K. (2002) · Oncogene · doi:10.1038/sj.onc.1206011 · Cited by 138
Xie, S., Wang, Q., Wu, H., Cogswell, J. P., Luo, L., Jhanwar‐Uniyal, M., & Dai, W. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104157200 · Cited by 137
Cell Cycle Regulation of the Human Polo-like Kinase (PLK) Promoter
Uchiumi, T., Longo, D. L., & Ferris, D. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.9166 · Cited by 135
Human Prk Is a Conserved Protein Serine/Threonine Kinase Involved in Regulating M Phase Functions
Ouyang, B., Pan, H., Lu, L., Li, J., Stambrook, P. J., Li, B., & Dai, W. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28646 · Cited by 133
Hamanaka, R., Maloid, S. C., Smith, M. R., O’Connell, C. D., Longo, D. L., & Ferris, D. K. (1994) · PubMed · Cited by 120
Polo-like kinase, a novel marker for cellular proliferation.
Yuan, J., Hörlin, A., Hock, B., Stutte, H. J., Rübsamen‐Waigmann, H., & Strebhardt, K. (1997) · Europe PMC (PubMed Central) · Cited by 117
Polo kinase: the choreographer of the mitotic stage?
Glover, D. M., Ohkura, H., & Tavares, Á. A. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.135.6.1681 · Cited by 96
Lake, R. J., & Jelinek, W. R. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7793-7801.1993 · Cited by 93
Kim, E.-J., Park, J. S., & Um, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200153200 · Cited by 83
Watanabe, K., Ozaki, T., Nakagawa, T., Miyazaki, K., Takahashi, M., Hosoda, M., Hayashi, S., Todo, S., & Nakagawara, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111281200 · Cited by 83
Self-citationConn, C. W., Hennigan, R. F., Dai, W. H., Sánchez, Y., & Stambrook, P. J. (2000) · PubMed · Cited by 81
Cell-cycle control: POLO-like kinases join the outer circle
Lane, H. A., & Nigg, E. A. (1997) · Trends in Cell Biology · doi:10.1016/s0962-8924(96)10051-9 · Cited by 75
PRK, a cell cycle gene localized to 8p21, is downregulated in head and neck cancer
Dai, W. H., Li, Y., Ouyang, B., Pan, H., Reissmann, P. T., Li, J., Wiest, J. S., Stambrook, P. J., Gluckman, J. L., Noffsinger, A. E., et al. (2000) · Genes Chromosomes and Cancer · Cited by 67
Lee, M. G., & Pedersen, P. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307031200 · Cited by 63
Nuclear Translocation of Plk1 Mediated by Its Bipartite Nuclear Localization Signal
Taniguchi, E., Toyoshima, F., & Nishida, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206307200 · Cited by 56
Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1
Ree, A. H., Bratland, Å., Nome, R. V., Stokke, T., & Fodstad, Ø. (2003) · Oncogene · doi:10.1038/sj.onc.1207000 · Cited by 38
Nakamura, Y., Ozaki, T., Nakagawara, A., & Sakiyama, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00333-x · Cited by 26
Self-citationCellular senescence and cancer
(1999) · doi:10.1002/(sici)1096-9896(199901)187:1
Cited by
Targeting polo-like kinase 1 for cancer therapy
Strebhardt, K., & Ullrich, A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1841 · Cited by 841
Mitotic catastrophe: a mechanism for avoiding genomic instability
Vitale, I., Galluzzi, L., Castedo, M., & Kroemer, G. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3115 · Cited by 834
“Several SAC components, including MPS1, Polo-like kinase 1 (PLK1) and perhaps AURKB, can phosphorylate TP53 (Ref”
BackgroundLost in Transcription: p21 Repression, Mechanisms, and Consequences
Gartel, A. L., & Radhakrishnan, S. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3995 · Cited by 818
Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
Strebhardt, K. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3184 · Cited by 653
Role of p53 in Cell Death and Human Cancers
Ozaki, T., & Nakagawara, A. (2011) · Cancers · doi:10.3390/cancers3010994 · Cited by 650
Self-citation
Metadata
- Authors
- Ando, K., Ozaki, T., Yamamoto, H., Furuya, K., Hosoda, M., Hayashi, S., Fukuzawa, M., & Nakagawara, A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-06
- Volume
- 279
- Issue
- 24
- Pages
- 25549-25561
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2040235495
- Cited by
- 264
- References
- 64
- FWCI
- 4.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.